Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pulmonary exacerbations in cystic fibrosis: it's time to be explicit!

× No keyword cloud information.

11 in total

1. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.

Authors: Joshua R Stokell; Raad Z Gharaibeh; Timothy J Hamp; Malcolm J Zapata; Anthony A Fodor; Todd R Steck
Journal: J Clin Microbiol Date: 2014-11-12 Impact factor: 5.948

Review 2. Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps?

Authors: Bonnie W Ramsey
Journal: Proc Am Thorac Soc Date: 2007-08-01

3. Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.

Authors: A Clement; A Tamalet; E Leroux; S Ravilly; B Fauroux; J-P Jais
Journal: Thorax Date: 2006-06-29 Impact factor: 9.139

Review 4. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Authors: Christopher H Goss; Jane L Burns
Journal: Thorax Date: 2007-04 Impact factor: 9.139

5. Aspergillus fumigatus Preexposure Worsens Pathology and Improves Control of Mycobacterium abscessus Pulmonary Infection in Mice.

Authors: Leticia Monin; Shail Mehta; Waleed Elsegeiny; Radha Gopal; Jeremy P McAleer; Tim D Oury; Jay Kolls; Shabaana A Khader
Journal: Infect Immun Date: 2018-02-20 Impact factor: 3.441

6. Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.

Authors: Jeffrey S Wagener; Lawrence Rasouliyan; Donald R VanDevanter; David J Pasta; Warren E Regelmann; Wayne J Morgan; Michael W Konstan
Journal: Pediatr Pulmonol Date: 2012-08-08

Review 7. Patient-reported outcomes in cystic fibrosis.

Authors: Christopher H Goss; Alexandra L Quittner
Journal: Proc Am Thorac Soc Date: 2007-08-01

8. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.

Authors: Warren E Regelmann; Michael S Schechter; Jeffrey S Wagener; Wayne J Morgan; David J Pasta; Eric P Elkin; Michael W Konstan
Journal: Pediatr Pulmonol Date: 2012-09-04

9. Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis.

Authors: Dayton Dmello; Ravi P Nayak; George M Matuschak
Journal: BMJ Open Date: 2011-07-18 Impact factor: 2.692

10. Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis.

Authors: M N Hurley; A H Amin Ariff; C Bertenshaw; J Bhatt; A R Smyth
Journal: J Cyst Fibros Date: 2012-03-20 Impact factor: 5.482